Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anika Therapeutics (ANIK) Interest Expenses (2020)

Anika Therapeutics (ANIK) has disclosed Interest Expenses for 1 consecutive years, with $900000.0 as the latest value for Q4 2020.

  • Quarterly Interest Expenses changed N/A to $900000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $900000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at $900000.0 for FY2020, N/A changed from the prior year.
  • Interest Expenses for Q4 2020 was $900000.0 at Anika Therapeutics.
  • The five-year high for Interest Expenses was $900000.0 in Q4 2020, with the low at $900000.0 in Q4 2020.